Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand

Acta Tropica

Volumn 117, Issue 2, 2011, Pages 82-85

  Srivastava, Saurabh ^a   Ahmad, Sohaib ^a   Shirazi, Nadia ^a   Kumar Verma, Sanjiv ^a   Puri, Prashant ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Complications; P Falciparum; P Vivax; Severe malaria

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ARTEMISIN DERIVATIVE; ASPARTATE AMINOTRANSFERASE; CHLOROQUINE; CREATININE; DOXYCYCLINE; PRIMAQUINE;

CHILD HEALTH; DISEASE PREVALENCE; GUIDELINE; INFECTIOUS DISEASE; MALARIA; WORLD HEALTH ORGANIZATION;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CENTRAL NERVOUS SYSTEM DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DISORIENTATION; EPIDEMIC; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; INDIA; JAUNDICE; KIDNEY FAILURE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PLASMODIUM VIVAX MALARIA; PLEURA EFFUSION; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEIZURE; SHOCK; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANEMIA; ANIMALS; FEMALE; HUMANS; INDIA; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; YOUNG ADULT;

INDIA; UTTARAKHAND;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 78650996885     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.10.001     Document Type: Article

References (27)

1. Agarwal S.K. Chronic kidney disease and its prevention in India. Kidney Int. 2005, 68:S41-S45.
2. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol. 2007, 23:533-539.
3. Barcus M.J., Basri H., Picarima H., Manyakori C., Sekartuti, Elyazar I., Bangs M.J., Maguire J.D., Baird J.K. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in north eastern Indonesian Papua. Am. J. Trop. Med. Hyg. 2007, 77:984-991.
4. Beg M.A., Khan R., Baig S.M., Gulzar Z., Hussain R., Smego R.A. Cerebral involvement in benign tertian malaria. Am. J. Trop. Med. Hyg. 2002, 67:230-232.
5. Claire L.M., James G.B., Kevin M. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 2004, 20:597-603.
6. Das B.S. Review articles-renal failure in malaria. J. Vector Borne Dis. 2004, 45:83-97.
7. Hay S.I., Guerra C.A., Tatem A.J., Noor A.M., Snow R.W. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 2004, 4:327-336.
8. Jadhav U.M., Patkar V.S., Kadam N.N. Thrombocytopenia in malaria-correlation with type and severity of malaria. J. Assoc. Phys. India 2004, 52:615-618.
9. Karunaweera N.D., Wijesekera S.K., Wanasekera D., Mendis K.N., Carter R. The paroxysm of Plasmodium vivax malaria. Trends Parasitol. 2003, 19:188-193.
10. Kochar D.K., Saxena V., Singh N., Kochar S.K., Kumar S.V., Das A. Plasmodium vivax malaria. Emerg. Infect. Dis. 2005, 11:132-134.
11. Koh K.H., Chew P.H., Kiyu A. A retrospective study of malaria infections in an intensive care unit of a general hospital in Malaysia. Singapore Med. J. 2004, 45:28-36.
12. Kondrachine A.V. Malaria in WHO Southeast Asia Region. Indian J. Malariol. 1992, 29:129-160.
13. Kumar A., Valecha N., Jain T., Dash A.P. Burden of Malaria in India: retrospective and prospective view. Am. J. Trop. Med. Hyg. 2007, 77:69-78.
14. Mani M.K. Prevention of chronic renal failure at the community level. Kidney Int. 2003, 63:S86-S89.
15. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64:97-106.
16. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2000, 415:673-679.
17. Mishra S.K., Mohanty S., Das B.S., Patnail J.K., Satpathy S.K., Mohanty D., Bose T.K. Hepatic changes in P falciparum malaria. Indian J. Malariol. 1992, 29:167-171.
18. Murray C.J.L., Lopez A.D. The global burden of disease 1990-2020: alternative projections of mortality and disability by cause for eight regions. Lancet 1997, 349:1498-1504.
19. Nicholas M.A., Tijandra H., Michael C.F.P., Enny K., Emiliana T., Ric N.P., Graeme P.M. Lung injury in vivax malaria: patho-physiological evidence for pulmonary vascular sequestration and post-treatment alveolar-capillary inflammation. J. Infect. Dis. 2007, 15:589-596.
20. Noppadon T., Vipa T., Srivicha K., Nutthanej L., Karnchana P., Kobsiri C., Sasikarn P., Shigeyuki K., Sornchai L., Polrat W. Minor liver profile dysfunctions in Plasmodium vivax. P. malariae and P. ovale patients and normalization after treatment. Korean J. Parasitol. 2006, 44:295-302.
21. Picot S. Is Plasmodium vivax still a paradigm for uncomplicated malaria?. Med. Mal. Infect. 2006, 36:406-413.
22. Ridley R.G. Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13362-13624.
23. Sina B. Focus on Plasmodium vivax. Trends Parasitol. 2002, 18:287-289.
24. Svenson J.E., MacLean J.D., Gyorkos T.W., Keystone J. Imported malaria. Clinical presentation and examination of symptomatic travellers. Arch. Intern. Med. 1995, 155:861-868.
25. Weatherall D.J., Miller L.H., Baruch D.I., Marsh K., Doumbo O.K., Casals-Pascual C., Roberts D.J. Malaria and the red cell. Hematol. Am. Soc. Hematol. Educ. Prog. 2002, 35-57.
26. Wilairatana P., Looareesuwan S., Charoenlarp P. Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop. Med. Parasitol. 1994, 45:298-302.
27. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 2000, 94. World Health Organization, S1/1-90.